IATF approves Phl participation in COVID-19 vaccine clinical trials

Maris Federez   •   May 24, 2020   •   1256

MANILA, Philippines — Upon the recommendation of the Department of Science and Technology (DOST), the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-MEID) has approved the proposed participation of the Philippines in clinical trials that seek to formulate a potential vaccine against coronavirus disease 2019 (COVID-19).

Based on IATF Resolution No.39 dated May 22, 2020, the task force has also ordered the creation of a sub-technical working group which will be led by the DOST.

The group will be coordinating with the four collaborating organizations composed of the Department of Health (DOH), the Food and Drug Administration (FDA), the Research Institute for Tropical Medicine (RITM), and the World Health Organization (WHO) with regard to the said clinical trials.

The IATF has also issued a directive to the FDA to facilitate the processing of necessary permits for the conduct of the clinical trials in the country.

The collaborating organizations for the clinical trials are the Adimmune Corporation, Academia Sinica, Chinese Academy of Science- Guangzhou Institute of Biomedicine and Health, the Sinopharm – Wuhan Institute of Biological Products, and the Beijing Institute.

Once the clinical trials are undertaken, these will be included in the FDA’s requirements for the registration process for the vaccine and the application for certificate of registration to make the vaccine available in the market.

The Philippines has initially participated in the WHO’s clinical trials, which include the testing of off-label drugs that show potential of being effective against COVID-19.

Meanwhile, the IATF has also approved the plans of the DOST to construct research centers for the local vaccine research development.

These include the Virology S&T Institute at the New Clark City in Tarlac and the reactivation of the Pharmaceutical Development Unit of the DOST-Industrial Technology Development Institute. —(from the report of Rosalie Coz) /mbmf

24K expired AstraZeneca vaccine doses sa Western Visayas, susuriin kung maaari pang gamitin – DOH

Robie de Guzman   •   December 3, 2021

Ipinapasuri na ng Department of Health (DOH)-Western Visayas kung maaari pang gamitin ang nasa 24,000 doses ng AstraZeneca COVID-19 vaccine na nag-expire noong November 30.

Bahagi ito ng libu-libong supply ng AstraZeneca vaccine na ipinadala sa Western Visayas noong buwan ng Oktubre.

Nasa 45,000 doses sa mga ito ang ipinadala sa Negros Occidental noong Nobyembre 8. Batay sa ulat ng provincial government, 14,920 doses pa ang natitira sa mga ito at hindi nagamit hanggang sa mag-expire noong Nobyembre 30.

Ayon kay Negros Occidental provincial administrator Atty. Rayfrando Diaz II, hindi ginamit ang mga nasabing bakuna dahil tumanggi umano ang mga local government unit (LGU) na tanggapin ito dahil sa nalalapit na expiration date.

“We value our vaccines. We want to use them. We do not delay, but we value more the vaccinees. We don’t want to inject vaccines that are about to expire,” ani Diaz.

Ang natitirang 10,000 doses naman ay nasa iba’t ibang lokalidad.

Ayon sa DOH regional office, ipinasasauli na nila ang mga nasabing bakuna upang masuri kung maaari pa itong gamitin.

Ayon kay Bea Camille Natalaray, ang tagapagsalita ng DOH Region 6, hihingan rin ng paliwanag ang concerned LGUs kung bakit hindi nagamit ang nasabing supply.

“Magpapasa sila ng incident report to explain bakit hindi nila na-utilize ang vaccine within the period of time. Ano ang mga factors konoconsider para next time maging part na siya ng ating mga guidelines or protocols or strategies,” ani Natalaray.

Sa ngayon ay hinihintay pa ng DOH-6 ang magiging desisyon ng central office kung dapat bang managot ang mga LGU sa pagkasira ng mga bakuna. (mula sa ulat ni Correspondent Lalaine Moreno)

Omicron COVID-19 variant spreads to 24 counties – WHO

Robie de Guzman   •   December 2, 2021

MANILA, Philippines – The Omicron variant of novel coronavirus disease (COVID-19) has been detected in 24 countries as of Wednesday, the World Health Organization (WHO) said.

The WHO said the United States is the latest country to be included in the list after it confirmed its first case of the heavily mutated and potentially more contagious variant as it continues to spread across borders.

The US said its first case of Omicron variant was a traveler in California who returned from South Africa on November 22. The case tested positive on Monday as reported by the US Centers for Disease Control and Prevention.

Other countries that have confirmed cases of Omicron variant include Australia, Canada, South Africa, Botswana, Nigeria, Saudi Arabia, Hong Kong, Germany, Israel, Italy, Belgium, the United Kingdom, and the Netherlands.

WHO director general Tedros Adhanon Ghebreyesus said the variant’s mutation should not surprise countries, as this is what viruses do.

He said available “tools” such as vaccines, should be used to contain the spread of the COVID-19 variant.

The WHO official also noted that the Delta variant is still responsible for most COVID cases worldwide and curbing its spread will also help contain Omicron.

“At the same time, we must not forget that we are already dealing with a highly transmissible, dangerous variant – the Delta variant, which currently accounts for almost all cases globally,” he said.

“We need to use the tools we already have to prevent transmission and save lives from Delta. And if we do that, we will also prevent transmission and save lives from Omicron,” he added.

“But if countries and individuals don’t do what they need to do to stop transmission of Delta, they won’t stop Omicron either,” he further stated.

Tedros said medical experts are still looking into the Omicron variant to understand how it affects transmission and its severity, and whether it will alter the effectiveness of COVID tests, treatment, and vaccines.

PH FDA approves COVID-19 vaccine booster jabs for general adult population

Robie de Guzman   •   December 1, 2021

MANILA, Philippines – The Food and Drug Administration (FDA) on Wednesday announced it has approved the administration of COVID-19 vaccine booster shots for the general adult population.

FDA director general Eric Domingo said the booster shots will be administered to all adults aged 18 years old and above, based on the assessment of benefit and risks

Domingo said the same brands and combinations like those recommended for health workers, senior citizens, and immunocompromised individuals will be applied to booster doses for the general adult population.

The FDA earlier said that vaccine brands Pfizer, AstraZeneca, SInovac, Moderna, and Sputnik V will be used as booster shots.

The guidelines on the distribution and use of booster shots will be released by the Department of Health.

“Sisimulan na rin natin, lumabas na yung EUA Amendment mula sa FDA. Nilagdaan na po ni director general Eric Domingo yung advisory na ito… Anytime this week,” said Health Secretary Francisco Duque III.

The government has started giving booster shots to health workers, senior citizens, and select immunocompromised individuals in November.

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.